Predictors of Anti-TNF Therapy Failure among Inflammatory Bowel Disease (IBD) Patients in Saudi Arabia: A Single-Center Study.

Othman AlharbiAbdulrahman M AljebreenNahla A AzzamMajid A AlmadiMaria SaeedBaraa HajkhderMullaissaHassan AsiriAbdullah AlmutairiYazed Sulaiman H Al-Ruthia

Published in: Journal of clinical medicine (2022)

Infliximab was shown to be more effective in the management of IBD, with lower incidence rates of treatment failure in comparison to adalimumab.

Keyphrases

ulcerative colitis
rheumatoid arthritis
end stage renal disease
newly diagnosed
ejection fraction
risk factors
prognostic factors
stem cells
replacement therapy
cell therapy